ProPhase Labs, Inc. Quarterly report pursuant to Section 13 or 15(d)

Leases (Tables)

3 Months Ended

Mar. 31, 2021

The following summarizes quantitative information about our operating leases (amounts in thousands):

	For the Three Months Ended March 31, 2021
Operating leases
Operating lease cost	$	204
Variable lease cost		-
Operating lease expense		204
Short-term lease rent expense		-
Total rent expense	$	204

	For the Three Months Ended March 31, 2021
Operating cash flows used in operating leases	$	(18	)
Right-of-use assets obtained in exchange for operating lease liabilities	$	-
Weighted-average remaining lease term – operating leases (in years)		10.1
Weighted-average discount rate – operating leases		10.00	%

Maturities of the Company’s operating leases, excluding short-term leases, are as follows (amounts in thousands):

Remaing Months Ended December 31, 2021	$	339
Year Ended December 31, 2022		774
Year Ended December 31, 2023		738
Year Ended December 31, 2024		747
Year Ended December 31, 2025		768
Thereafter		4,659
Total		8,025
Less present value discount		(3,193	)
Operating lease liabilities	$	4,832